APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artemisinin and Derivatives Market Outlook and Growth Opportunities 2026

Report ID 173226990423 December 2025194 pages

Choose your research edition.

Industry ResearchArtemisinin and Derivatives Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin and Derivatives Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Artemisinin and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin and Derivatives Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin and Derivatives Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Artemisinin and Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artemisinin and Derivatives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artemisinin and Derivatives market include Ipca Laboratories, Guilin Nantang Pharmaceutical, KPC Pharmaceuticals, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Cerata Pharmaceuticals and Aqre Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Artemisinin and Derivatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artemisinin and Derivatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artemisinin and Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artemisinin and Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Artemisinin and Derivatives Segment by Company

Ipca Laboratories

Guilin Nantang Pharmaceutical

KPC Pharmaceuticals

Chongqing Kerui Nanhai Pharmaceutical

Sichuan Xieli Pharmaceutical

Cerata Pharmaceuticals

Aqre Group

Artemisinin and Derivatives Segment by Type

Artemether

Artesunate

Artemisinin

Dihydroartemisinin

Artemisinin and Derivatives Segment by Application

Antitumor and Anti-inflammatory Drugs

Antimalarial Drugs

Artemisinin and Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artemisinin and Derivatives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Artemisinin and Derivatives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artemisinin and Derivatives significant trends, drivers, influence factors in global and regions.

6. To analyze Artemisinin and Derivatives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artemisinin and Derivatives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artemisinin and Derivatives industry.

Chapter 3: Detailed analysis of Artemisinin and Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Artemisinin and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Artemisinin and Derivatives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artemisinin and Derivatives Industry Trends Table 2. Artemisinin and Derivatives Industry Drivers Table 3. Artemisinin and Derivatives Industry Opportunities and Challenges Table 4. Artemisinin and Derivatives Industry Restraints Table 5. Global Artemisinin and Derivatives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artemisinin and Derivatives Revenue Share by Company (2021-2026) Table 7. Global Artemisinin and Derivatives Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Artemisinin and Derivatives Sales Volume Share by Company (2021-2026) Table 9. Global Artemisinin and Derivatives Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Artemisinin and Derivatives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Artemisinin and Derivatives Key Company Manufacturing Base & Headquarters Table 12. Global Artemisinin and Derivatives Company, Product Type & Application Table 13. Global Artemisinin and Derivatives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Artemisinin and Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Artemether Table 18. Significant Companies of Artesunate Table 19. Significant Companies of Artemisinin Table 20. Significant Companies of Dihydroartemisinin Table 21. Global Artemisinin and Derivatives Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Artemisinin and Derivatives Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Artemisinin and Derivatives Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Artemisinin and Derivatives Sales Volume Share by Type (2021-2026) Table 25. Global Artemisinin and Derivatives Sales Volume Share by Type (2027-2032) Table 26. Global Artemisinin and Derivatives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Artemisinin and Derivatives Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Artemisinin and Derivatives Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Artemisinin and Derivatives Sales Value Share by Type (2021-2026) Table 30. Global Artemisinin and Derivatives Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Antitumor and Anti-inflammatory Drugs Table 32. Significant Companies of Antimalarial Drugs Table 33. Global Artemisinin and Derivatives Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Artemisinin and Derivatives Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Artemisinin and Derivatives Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Artemisinin and Derivatives Sales Volume Share by Application (2021-2026) Table 37. Global Artemisinin and Derivatives Sales Volume Share by Application (2027-2032) Table 38. Global Artemisinin and Derivatives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Artemisinin and Derivatives Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Artemisinin and Derivatives Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Artemisinin and Derivatives Sales Value Share by Application (2021-2026) Table 42. Global Artemisinin and Derivatives Sales Value Share by Application (2027-2032) Table 43. Global Artemisinin and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Artemisinin and Derivatives Sales by Region (2021-2026) & (Tons) Table 45. Global Artemisinin and Derivatives Sales Market Share by Region (2021-2026) Table 46. Global Artemisinin and Derivatives Sales by Region (2027-2032) & (Tons) Table 47. Global Artemisinin and Derivatives Sales Market Share by Region (2027-2032) Table 48. Global Artemisinin and Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Artemisinin and Derivatives Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Artemisinin and Derivatives Sales Value Share by Region (2021-2026) Table 51. Global Artemisinin and Derivatives Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Artemisinin and Derivatives Sales Value Share by Region (2027-2032) Table 53. Global Artemisinin and Derivatives Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Artemisinin and Derivatives Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Artemisinin and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Artemisinin and Derivatives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 58. Global Artemisinin and Derivatives Sales Market Share by Country (2021-2026) Table 59. Global Artemisinin and Derivatives Sales by Country (2027-2032) & (Tons) Table 60. Global Artemisinin and Derivatives Sales Market Share by Country (2027-2032) Table 61. Global Artemisinin and Derivatives Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Artemisinin and Derivatives Sales Value Market Share by Country (2021-2026) Table 63. Global Artemisinin and Derivatives Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Artemisinin and Derivatives Sales Value Market Share by Country (2027-2032) Table 65. Ipca Laboratories Company Information Table 66. Ipca Laboratories Business Overview Table 67. Ipca Laboratories Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Ipca Laboratories Artemisinin and Derivatives Product Portfolio Table 69. Ipca Laboratories Recent Development Table 70. Guilin Nantang Pharmaceutical Company Information Table 71. Guilin Nantang Pharmaceutical Business Overview Table 72. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 74. Guilin Nantang Pharmaceutical Recent Development Table 75. KPC Pharmaceuticals Company Information Table 76. KPC Pharmaceuticals Business Overview Table 77. KPC Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolio Table 79. KPC Pharmaceuticals Recent Development Table 80. Chongqing Kerui Nanhai Pharmaceutical Company Information Table 81. Chongqing Kerui Nanhai Pharmaceutical Business Overview Table 82. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 84. Chongqing Kerui Nanhai Pharmaceutical Recent Development Table 85. Sichuan Xieli Pharmaceutical Company Information Table 86. Sichuan Xieli Pharmaceutical Business Overview Table 87. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 89. Sichuan Xieli Pharmaceutical Recent Development Table 90. Cerata Pharmaceuticals Company Information Table 91. Cerata Pharmaceuticals Business Overview Table 92. Cerata Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolio Table 94. Cerata Pharmaceuticals Recent Development Table 95. Aqre Group Company Information Table 96. Aqre Group Business Overview Table 97. Aqre Group Artemisinin and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Aqre Group Artemisinin and Derivatives Product Portfolio Table 99. Aqre Group Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Artemisinin and Derivatives Distributors List Table 103. Artemisinin and Derivatives Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Artemisinin and Derivatives Product Image Figure 2. Global Artemisinin and Derivatives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Artemisinin and Derivatives Sales (2021-2032) & (Tons) Figure 5. Global Artemisinin and Derivatives Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Artemisinin and Derivatives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Artemether Image Figure 10. Artesunate Image Figure 11. Artemisinin Image Figure 12. Dihydroartemisinin Image Figure 13. Global Artemisinin and Derivatives Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Artemisinin and Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Artemisinin and Derivatives Sales Volume Share by Type (2021-2032) Figure 16. Global Artemisinin and Derivatives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Artemisinin and Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Artemisinin and Derivatives Sales Value Share by Type (2021-2032) Figure 19. Antitumor and Anti-inflammatory Drugs Image Figure 20. Antimalarial Drugs Image Figure 21. Global Artemisinin and Derivatives Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Artemisinin and Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Artemisinin and Derivatives Sales Volume Share by Application (2021-2032) Figure 24. Global Artemisinin and Derivatives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Artemisinin and Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Artemisinin and Derivatives Sales Value Share by Application (2021-2032) Figure 27. Global Artemisinin and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Artemisinin and Derivatives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Artemisinin and Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Artemisinin and Derivatives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Artemisinin and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 32. North America Artemisinin and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Artemisinin and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Artemisinin and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Artemisinin and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Artemisinin and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Artemisinin and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 38. South America Artemisinin and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Artemisinin and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Artemisinin and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Artemisinin and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Artemisinin and Derivatives Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Artemisinin and Derivatives Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Artemether
  • Artesunate
  • Artemisinin
  • Dihydroartemisinin
Applications
  • Antitumor and Anti-inflammatory Drugs
  • Antimalarial Drugs
Companies covered
  • Ipca Laboratories
  • Guilin Nantang Pharmaceutical
  • KPC Pharmaceuticals
  • Chongqing Kerui Nanhai Pharmaceutical
  • Sichuan Xieli Pharmaceutical
  • Cerata Pharmaceuticals
  • Aqre Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artemisinin and Derivatives Sales Value (2021-2032)
  4. 1.2.2 Global Artemisinin and Derivatives Sales Volume (2021-2032)
  5. 1.2.3 Global Artemisinin and Derivatives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Artemisinin and Derivatives Market Dynamics
  1. 2.1 Artemisinin and Derivatives Industry Trends
  2. 2.2 Artemisinin and Derivatives Industry Drivers
  3. 2.3 Artemisinin and Derivatives Industry Opportunities and Challenges
  4. 2.4 Artemisinin and Derivatives Industry Restraints
3 Artemisinin and Derivatives Market by Company
  1. 3.1 Global Artemisinin and Derivatives Company Revenue Ranking in 2025
  2. 3.2 Global Artemisinin and Derivatives Revenue by Company (2021-2026)
  3. 3.3 Global Artemisinin and Derivatives Sales Volume by Company (2021-2026)
  4. 3.4 Global Artemisinin and Derivatives Average Price by Company (2021-2026)
  5. 3.5 Global Artemisinin and Derivatives Company Ranking (2024-2026)
  6. 3.6 Global Artemisinin and Derivatives Company Manufacturing Base and Headquarters
  7. 3.7 Global Artemisinin and Derivatives Company Product Type and Application
  8. 3.8 Global Artemisinin and Derivatives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Artemisinin and Derivatives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Artemisinin and Derivatives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Artemisinin and Derivatives Market by Type
  1. 4.1 Artemisinin and Derivatives Type Introduction
  2. 4.1.1 Artemether
  3. 4.1.2 Artesunate
  4. 4.1.3 Artemisinin
  5. 4.1.4 Dihydroartemisinin
  6. 4.2 Global Artemisinin and Derivatives Sales Volume by Type
  7. 4.2.1 Global Artemisinin and Derivatives Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Artemisinin and Derivatives Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Artemisinin and Derivatives Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Artemisinin and Derivatives Sales Value by Type
  11. 4.3.1 Global Artemisinin and Derivatives Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Artemisinin and Derivatives Sales Value by Type (2021-2032)
  13. 4.3.3 Global Artemisinin and Derivatives Sales Value Share by Type (2021-2032)
5 Artemisinin and Derivatives Market by Application
  1. 5.1 Artemisinin and Derivatives Application Introduction
  2. 5.1.1 Antitumor and Anti-inflammatory Drugs
  3. 5.1.2 Antimalarial Drugs
  4. 5.2 Global Artemisinin and Derivatives Sales Volume by Application
  5. 5.2.1 Global Artemisinin and Derivatives Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Artemisinin and Derivatives Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Artemisinin and Derivatives Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Artemisinin and Derivatives Sales Value by Application
  9. 5.3.1 Global Artemisinin and Derivatives Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Artemisinin and Derivatives Sales Value by Application (2021-2032)
  11. 5.3.3 Global Artemisinin and Derivatives Sales Value Share by Application (2021-2032)
6 Artemisinin and Derivatives Regional Sales and Value Analysis
  1. 6.1 Global Artemisinin and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artemisinin and Derivatives Sales by Region (2021-2032)
  3. 6.2.1 Global Artemisinin and Derivatives Sales by Region: 2021-2026
  4. 6.2.2 Global Artemisinin and Derivatives Sales by Region (2027-2032)
  5. 6.3 Global Artemisinin and Derivatives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Artemisinin and Derivatives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Artemisinin and Derivatives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Artemisinin and Derivatives Sales Value by Region (2027-2032)
  9. 6.5 Global Artemisinin and Derivatives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Artemisinin and Derivatives Sales Value (2021-2032)
  12. 6.6.2 North America Artemisinin and Derivatives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Artemisinin and Derivatives Sales Value (2021-2032)
  15. 6.7.2 Europe Artemisinin and Derivatives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Artemisinin and Derivatives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Artemisinin and Derivatives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Artemisinin and Derivatives Sales Value (2021-2032)
  21. 6.9.2 South America Artemisinin and Derivatives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Artemisinin and Derivatives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Artemisinin and Derivatives Sales Value Share by Country, 2025 VS 2032
7 Artemisinin and Derivatives Country-level Sales and Value Analysis
  1. 7.1 Global Artemisinin and Derivatives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artemisinin and Derivatives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Artemisinin and Derivatives Sales by Country (2021-2032)
  4. 7.3.1 Global Artemisinin and Derivatives Sales by Country (2021-2026)
  5. 7.3.2 Global Artemisinin and Derivatives Sales by Country (2027-2032)
  6. 7.4 Global Artemisinin and Derivatives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Artemisinin and Derivatives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Artemisinin and Derivatives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Artemisinin and Derivatives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Artemisinin and Derivatives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Artemisinin and Derivatives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ipca Laboratories
  2. 8.1.1 Ipca Laboratories Company Information
  3. 8.1.2 Ipca Laboratories Business Overview
  4. 8.1.3 Ipca Laboratories Artemisinin and Derivatives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ipca Laboratories Artemisinin and Derivatives Product Portfolio
  6. 8.1.5 Ipca Laboratories Recent Developments
  7. 8.2 Guilin Nantang Pharmaceutical
  8. 8.2.1 Guilin Nantang Pharmaceutical Company Information
  9. 8.2.2 Guilin Nantang Pharmaceutical Business Overview
  10. 8.2.3 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolio
  12. 8.2.5 Guilin Nantang Pharmaceutical Recent Developments
  13. 8.3 KPC Pharmaceuticals
  14. 8.3.1 KPC Pharmaceuticals Company Information
  15. 8.3.2 KPC Pharmaceuticals Business Overview
  16. 8.3.3 KPC Pharmaceuticals Artemisinin and Derivatives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolio
  18. 8.3.5 KPC Pharmaceuticals Recent Developments
  19. 8.4 Chongqing Kerui Nanhai Pharmaceutical
  20. 8.4.1 Chongqing Kerui Nanhai Pharmaceutical Company Information
  21. 8.4.2 Chongqing Kerui Nanhai Pharmaceutical Business Overview
  22. 8.4.3 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolio
  24. 8.4.5 Chongqing Kerui Nanhai Pharmaceutical Recent Developments
  25. 8.5 Sichuan Xieli Pharmaceutical
  26. 8.5.1 Sichuan Xieli Pharmaceutical Company Information
  27. 8.5.2 Sichuan Xieli Pharmaceutical Business Overview
  28. 8.5.3 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolio
  30. 8.5.5 Sichuan Xieli Pharmaceutical Recent Developments
  31. 8.6 Cerata Pharmaceuticals
  32. 8.6.1 Cerata Pharmaceuticals Company Information
  33. 8.6.2 Cerata Pharmaceuticals Business Overview
  34. 8.6.3 Cerata Pharmaceuticals Artemisinin and Derivatives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolio
  36. 8.6.5 Cerata Pharmaceuticals Recent Developments
  37. 8.7 Aqre Group
  38. 8.7.1 Aqre Group Company Information
  39. 8.7.2 Aqre Group Business Overview
  40. 8.7.3 Aqre Group Artemisinin and Derivatives Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Aqre Group Artemisinin and Derivatives Product Portfolio
  42. 8.7.5 Aqre Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artemisinin and Derivatives Value Chain Analysis
  2. 9.1.1 Artemisinin and Derivatives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artemisinin and Derivatives Sales Mode & Process
  6. 9.2 Artemisinin and Derivatives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artemisinin and Derivatives Distributors
  9. 9.2.3 Artemisinin and Derivatives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst